Skip to content

Prospective, randomized, and controlled clinical study of follow-up breast cancer patients based on interpersonal continuity "Internet plus Pharmacy"

Prospective, randomized, and controlled clinical study of follow-up breast cancer patients based on interpersonal continuity "Internet plus Pharmacy"

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300078817
Enrollment
Unknown
Registered
2023-12-19
Start date
2023-07-28
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Sponsors

The Second Affiliated Hospital of Fujian Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Patients diagnosed as breast cancer stage I-III for the first time (refer to AJCC stage); ? Between the ages of 18 and 80; ? Expected survival period greater than half a year; ? Patients with communication skills, no significant cognitive impairment, and the ability to use smartphones; ? Patients who are willing to cooperate with follow-up for a long time and are able to return to the clinic on time; ? Understand the research process, agree to participate in this research project, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: ? Patients with concomitant other tumors; ? Has undergone treatment in an external hospital (surgery, radiotherapy, chemotherapy, etc.); ? Patients with difficulty in verbal communication; ? Patients with poor compliance and resistance to examination; ? Severe cognitive impairment and lack of self-care ability; ? Patients who also participate in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Adverse reaction rate;

Secondary

MeasureTime frame
Quality of life score;Medication compliance;Breast cancer diagnosis and treatment knowledge score;BMI;Incidence of limb edema on the affected side;Unexpected number of outpatient and emergency visits;Number of drug-related issues;

Countries

China

Contacts

Public ContactZhang Yin

The Second Affiliated Hospital of Fujian Medical University

zyin1973@163.com+86 133 2857 9972

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026